Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2014 2
2015 2
2018 2
2019 4
2020 2
2021 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
The case for assessing the full value of new tuberculosis vaccines.
Gebreselassie N, Hutubessy R, Vekemans J, den Boon S, Kasaeva T, Zignol M. Gebreselassie N, et al. Eur Respir J. 2020 Mar 20;55(3):1902414. doi: 10.1183/13993003.02414-2019. Print 2020 Mar. Eur Respir J. 2020. PMID: 32198269 Free article. No abstract available.
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Deol A, Scarponi D, Iskauskas A, Bakker R, Quaife M, Malhotra S, Gebreselassie N, Zignol M, Hutubessy RCW, Giersing B, Jit M, Harris RC, Menzies NA, White RG. Clark RA, et al. Among authors: gebreselassie n. Lancet Glob Health. 2023 Apr;11(4):e546-e555. doi: 10.1016/S2214-109X(23)00045-1. Lancet Glob Health. 2023. PMID: 36925175 Free PMC article.
A global strategy for tuberculosis research and innovation.
Gebreselassie N, Kasaeva T, Zignol M. Gebreselassie N, et al. Eur Respir J. 2020 Nov 12;56(5):2003539. doi: 10.1183/13993003.03539-2020. Print 2020 Nov. Eur Respir J. 2020. PMID: 33184100 Free article. No abstract available.
Tuberculosis research and development: seeding the future.
Lienhardt C, Zumla A, Gebreselassie N, Frick M, Gray G, Kasaeva T, Raviglione M. Lienhardt C, et al. Among authors: gebreselassie n. Lancet Respir Med. 2018 Apr;6(4):242-244. doi: 10.1016/S2213-2600(18)30050-X. Lancet Respir Med. 2018. PMID: 29595503 Free article. No abstract available.
A bibliometric analysis of tuberculosis research, 2007-2016.
Nafade V, Nash M, Huddart S, Pande T, Gebreselassie N, Lienhardt C, Pai M. Nafade V, et al. Among authors: gebreselassie n. PLoS One. 2018 Jun 25;13(6):e0199706. doi: 10.1371/journal.pone.0199706. eCollection 2018. PLoS One. 2018. PMID: 29940004 Free PMC article.
Eosinophil-derived IL-10 supports chronic nematode infection.
Huang L, Gebreselassie NG, Gagliardo LF, Ruyechan MC, Lee NA, Lee JJ, Appleton JA. Huang L, et al. Among authors: gebreselassie ng. J Immunol. 2014 Oct 15;193(8):4178-87. doi: 10.4049/jimmunol.1400852. Epub 2014 Sep 10. J Immunol. 2014. PMID: 25210122 Free PMC article.
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy A, Clark RA, Quaife M, Weerasuriya CK, Mukandavire C, Bakker R, Deol AK, Malhotra S, Gebreselassie N, Zignol M, Sim SY, Hutubessy RCW, Baena IG, Nishikiori N, Jit M, White RG, Menzies NA. Portnoy A, et al. Among authors: gebreselassie n. PLoS Med. 2023 Jan 24;20(1):e1004155. doi: 10.1371/journal.pmed.1004155. eCollection 2023 Jan. PLoS Med. 2023. PMID: 36693081 Free PMC article.
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries.
Portnoy A, Clark RA, Weerasuriya CK, Mukandavire C, Quaife M, Bakker R, Garcia Baena I, Gebreselassie N, Zignol M, Jit M, White RG, Menzies NA. Portnoy A, et al. Among authors: gebreselassie n. BMJ Glob Health. 2023 Jul;8(7):e012466. doi: 10.1136/bmjgh-2023-012466. BMJ Glob Health. 2023. PMID: 37438049 Free PMC article.
18 results